Sotera Health (NASDAQ:SHC) Shares Sold by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. lessened its position in Sotera Health (NASDAQ:SHC) by 17.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 39,462 shares of the company’s stock after selling 8,498 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Sotera Health were worth $659,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of SHC. CWM LLC increased its stake in Sotera Health by 86.1% during the second quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after purchasing an additional 993 shares during the period. GAMMA Investing LLC increased its stake in Sotera Health by 125.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock worth $50,000 after buying an additional 1,660 shares during the period. Point72 DIFC Ltd lifted its holdings in Sotera Health by 556.6% during the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock worth $78,000 after buying an additional 5,544 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in Sotera Health in the 3rd quarter valued at approximately $91,000. Finally, Acadian Asset Management LLC grew its stake in shares of Sotera Health by 728.0% in the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after acquiring an additional 8,248 shares in the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Trading Up 1.2 %

NASDAQ:SHC opened at $13.10 on Friday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The stock has a market cap of $3.71 billion, a P/E ratio of 52.40 and a beta of 2.08. The stock has a 50-day simple moving average of $15.32 and a 200-day simple moving average of $14.00.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $285.47 million during the quarter, compared to analysts’ expectations of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.18 earnings per share. As a group, analysts anticipate that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research note on Thursday, November 21st. Barclays boosted their price objective on Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 6th. Finally, Citigroup raised their target price on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Sotera Health currently has a consensus rating of “Moderate Buy” and an average target price of $16.50.

Insider Buying and Selling

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. This trade represents a 16.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 55.12% of the stock is owned by company insiders.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.